Literature DB >> 11381852

Cutaneous Acanthamoeba in a patient with AIDS: a case study with a review of new therapy; quiz 386.

S Levine1, A E Goldstein, M Dahdouh, P Blank, C Hoffman, C A Gropper.   

Abstract

GOAL: To describe the presenting signs of an Acanthamoeba infection.
OBJECTIVES: Upon completion of this activity, dermatologists and general practitioners should be able to: 1. Discuss the clinical presentation of Acanthamoeba infection. 2. Describe the conditions that make a patient susceptible to Acanthamoeba. 3. Outline treatment options for Acanthamoeba infection. CME: This article has been peer reviewed and approved by Michael Fisher, MD, Professor of Medicine, Albert Einstein College of Medicine. REVIEW DATE: April 2001. This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Albert Einstein College of Medicine and Quadrant HealthCom, Inc. The Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians. Albert Einstein College of Medicine designates this educational activity for a maximum of 1.0 hour in category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity. This activity has been planned and produced in accordance with ACCME Essentials.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11381852

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  5 in total

1.  Isolation and identification of pathogenic Acanthamoeba strains in Tenerife, Canary Islands, Spain from water sources.

Authors:  Jacob Lorenzo-Morales; Antonio Ortega-Rivas; Pilar Foronda; Enrique Martínez; Basilio Valladares
Journal:  Parasitol Res       Date:  2005-01-28       Impact factor: 2.289

2.  Acanthamoeba castellanii promotion of in vitro survival and transmission of coxsackie b3 viruses.

Authors:  A Mattana; C Serra; E Mariotti; G Delogu; P L Fiori; P Cappuccinelli
Journal:  Eukaryot Cell       Date:  2006-04

3.  In vitro evaluation of the effectiveness of the macrolide rokitamycin and chlorpromazine against Acanthamoeba castellanii.

Authors:  A Mattana; G Biancu; L Alberti; A Accardo; G Delogu; P L Fiori; P Cappuccinelli
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

Review 4.  Acanthamoeba spp. as agents of disease in humans.

Authors:  Francine Marciano-Cabral; Guy Cabral
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

5.  Diagnosis of infections caused by pathogenic free-living amoebae.

Authors:  Bruno da Rocha-Azevedo; Herbert B Tanowitz; Francine Marciano-Cabral
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-08-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.